MotherToBaby

Medications and More during pregnancy and breastfeeding

Search

866.626.6847

Molnupiravir

Selected References:

  • DeSisto CL, et al. 2021. Risk of stillbirth among women with and without COVID-19 at delivery hospitalization – United States, March 2020 – September 2021. https://www.cdc.gov/mmwr/volumes/70/wr/mm7047e1.htm?s_cid=mm7047e1_w
  • Kasehagen L, et al. 2021. COVID-19 – associated deaths after SARS-CoV-2 infection during pregnancy – Mississippi, March 1, 2020 – October 6, 2021.
  • Food and Drug Administration. 2021. Fact Sheet for Healthcare Providers: Emergency Use Authorization for Molnupiravir. https://www.fda.gov/media/155054/download
  • Merck & Co. Center for Drug Evaluation and Research Antimicrobial Drugs Advisory Committee Meeting Briefing Document. 2021. Molnupiravir. https://www.fda.gov/media/154421/download
  • 2021. Molnupiravir. https://www.fda.gov/media/154472/download
  • Regan AK, et al. 2021. SARS-CoV-2 infection during pregnancy and associated perinatal health outcomes: a national US cohort study. J Infect Dis Dec 27; jiab626. doi: 10.1093/infdis/jiab626.

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $6,000,000 with zero percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, HRSA, HHS, or the U.S. Government.